OICR Innovation Implementation Supplement- LOI Due Jan. 26th
RFA information session: January 12, 2022, 10-11 a.m. ET (register here. If you are unable to attend, a recording of the session will be made available on this website)
Notice of Intent (NOI) deadline: January 26 by 5 p.m. ET
Letter of Intent (LOI) deadline: January 26, 2022 by 5 p.m. ET
LOI results communicated: Week of March 7, 2022
Full application deadline: April 28, 2022 by 5 p.m. ET
Notification of results: End of June 2022
Funding to begin: July 1, 2022
The Ontario Institute for Cancer Research (OICR) is inviting applications for the Innovation to Implementation Supplement (I2IS), which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to inform adoption of OICR research assets into policy or health care. OICR is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions. I2IS is a supplement for OICR research projects supported within the last five years to move them from an experimental phase towards clinical use.
Up to $100,000 per year, inclusive of overhead, for a maximum of one year. The annual budget for the entire I2IS funding stream is $600,000. OICR funding is only tenable in Ontario and can only be disbursed to not-for-profit entities.
For full program information and details on how to apply please visit https://oicr.on.ca/oicr-innovation-to-implementation-supplement-request-for-applications/
Leave a ReplyWant to join the discussion?
Feel free to contribute!